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Introduction {#sec005}
============

More than 312 million major surgical procedures are performed worldwide each year.\[[@pone.0219145.ref001]\] Of these, approximately five million major non-cardiac surgeries occur in the United States\[[@pone.0219145.ref002]\] \[[@pone.0219145.ref003]\] It is estimated that non-cardiac surgery has a complication rate as high as 11%, and 42% of these complications are cardiovascular in nature.\[[@pone.0219145.ref003]\] Within 30-days after non-cardiac surgery, cardiovascular complications are the leading cause of peri-operative death,\[[@pone.0219145.ref002]\] with a rate currently estimated at 1.7% in the United States,\[[@pone.0219145.ref002]\] that is similar worldwide.\[[@pone.0219145.ref003]\] Although the occurrence of peri-operative adverse cardiovascular events has declined over the past decade,\[[@pone.0219145.ref002]\] the continued growth in the aged population along with its associated co-morbidities presents a burgeoning challenge to mitigate surgical risk in these progressively complicated patients.

Comprehensive consideration of the type of surgery that is to be performed along with careful and appropriate evaluation of each specific patient aims to yield a benefit-risk assessment that guides subsequent decisions and patient management. Stress testing is among the most fundamental and widely used tools in the evaluation of patients with cardiovascular disease (CVD). Despite more than four decades of research, very few randomized trials have addressed the value of pre-operative stress testing.

Continued advances in surgical techniques and peri-operative monitoring have counterbalanced changes in patient demographics in those undergoing non-cardiac surgeries. Indiscriminate routine stress testing may lead to further unnecessary downstream testing, including additional medical treatments, costly invasive procedures that may delay the planned surgical procedure or possibly increase perioperative adverse event rates that provide no benefit to the patient.\[[@pone.0219145.ref004]\]

Therefore, the objective of this study is to assess the type and quality of available evidence in a comprehensive and statistically rigorous evaluation regarding the effectiveness of pre-operative stress testing in reducing 30-day post -operative mortality following non -cardiac surgery. We hypothesized that the current evidence is not adequate for setting guidelines due to lack of studies of sufficient quality. We also addressed the following secondary questions: 1) does pre-operative stress testing change relative to the era in which the surgery was performed, 2) does the benefit of reduction in mortality due to pre-operative stress testing differ relative to the types of surgery performed, 3) are there differences in the benefit of reduction in mortality related to pre-operative testing relative to the type of test that was performed, and 4) are there variables derived from pre-operative stress testing that predict 30 day post-operative mortality or other cardiovascular events including non-fatal myocardial infarction, heart failure, or stroke.

Materials and methods {#sec006}
=====================

This pooled data analysis of aggregate data from published studies was performed according to a predefined protocol in PROSPERO \#CRD42016049212. Ethics committee approval was not required since only aggregate data was used from published literature.

Search strategy and selection criteria {#sec007}
--------------------------------------

We performed a systematic literature search in MEDLINE, EMBASE, and CENTRAL from inception to January 27, 2016, of all studies with non-cardiac surgery and stress testing in humans. The search criteria in three databases are presented in [S1 Appendix](#pone.0219145.s021){ref-type="supplementary-material"}. The search yielded 1807 studies. All abstracts were obtained and screened using inclusion and exclusion criteria presented in [S2 Appendix](#pone.0219145.s022){ref-type="supplementary-material"}. Only studies in English, and among adults were included from 10 different non-cardiac surgical procedures of peripheral vascular, thoracic, abdominal, gynecological, urological, renal transplant, liver transplant, orthopedic, gastric bypass, abdominal aortic aneurysm procedures. The types of stress tests used were exercise tolerance, pharmacological nuclear, adenosine nuclear, Persantine nuclear, dobutamine nuclear, exercise nuclear, exercise echocardiogram, dobutamine echocardiogram, cardiopulmonary, metabolic, stress test with gas exchange analysis and six-minute walk test. We did not apply restrictions based on outcomes. Studies with a sample size of \<15 were excluded. An updated search was performed on June 4, 2019 and assessment of new abstracts revealed no new observational studies or clinical trials after our search date. Therefore, we did not update our search.

Data extraction {#sec008}
---------------

Two authors (H. N. and S. I.) independently screened the abstracts ([S3 Appendix](#pone.0219145.s023){ref-type="supplementary-material"}). The concordance between screeners was high-agreement of 90.4% and Kappa of 75.4%. We obtained the full text of 181 articles and further screened the full text using inclusion and exclusion criteria ([S4 Appendix](#pone.0219145.s024){ref-type="supplementary-material"}). Full texts were further assessed, and 97 articles were excluded for the same eligibility criteria. There were 84 articles remaining (79 distinct studies) that were used for the final analysis.\[[@pone.0219145.ref005]--[@pone.0219145.ref088]\] The details of the screening are presented in a flowchart presented in [Fig 1](#pone.0219145.g001){ref-type="fig"}. We extracted the total number of patients in the cohorts of patients who received a stress test and those patients who did not receive testing prior to non-cardiac surgery. The primary outcome was 30-day mortality and we extracted the number of deaths in patients who received a stress test and those who did not. The other variables we extracted were study characteristics such as demographic, methodologic, design, length of follow up, type of surgery and type of stress testing. For the randomized trials, as components of methodological quality, we assessed concealment of allocation, blinding of investigators adjudicating clinical events, and the inclusion of all randomized individuals in the analysis according to the intention-to-treat principle.\[[@pone.0219145.ref089], [@pone.0219145.ref090]\] To evaluate study quality of cohort studies, we used the individual criteria of the Newcastle-Ottawa Quality Assessment Scale ([S5 Appendix](#pone.0219145.s025){ref-type="supplementary-material"}).\[[@pone.0219145.ref091]\] All data, including outcomes data, were extracted by four of the authors: HN., SI, CL, GJB.

![Flow chart.\
*Adapted from*: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). *P*referred *R*eporting *I*terns for *S*ystematic Reviews and *M*eta-*A*nalyses: The PRISMA Statement. PLoS Med 6(7): el000097. doi:[10.1371/journal.pmedl000097](https://doi.org/10.1371/journal.pmedl000097). For more information, visit [www.prisma-statement.org](https://www.prisma-statement.org).](pone.0219145.g001){#pone.0219145.g001}

Stratification and sensitivity analysis {#sec009}
---------------------------------------

The stratification variables were pre-specified and were the type of surgery performed (vascular, lung, abdominal, and other), type of stress tests administered (exercise-electrocardiogram, nuclear stress, echocardiographic stress, cardiopulmonary testing), evidence of ischemia, time of study publication, and the country from where the data originated. Post-hoc exploration by peak exercise work rate or other test-specific measured variables showed insufficient extractable information. Sensitivity analysis was performed using study quality variables extracted using individual criteria of the Newcastle-Ottawa Quality Assessment scale.\[[@pone.0219145.ref091]\]

Data analysis {#sec010}
-------------

We used a two-step approach in our analyses. In the first step, we selected those studies which had a comparison of stress test and no stress test and had information on 30-day mortality. In the second step, we conducted a meta-analysis on all studies with a single cohort of those patients who received stress testing and had information on 30-day mortality. In the comparison of stress test versus no stress test, we calculated risk ratios (RR) and 95% confidence intervals (95% CI) as measures of treatment effect using the DerSimonian and Laird random-effects model to combine estimates across studies.\[[@pone.0219145.ref092]\] We determined heterogeneity across studies using the I^2^ statistic and constructed funnel plots.\[[@pone.0219145.ref093]--[@pone.0219145.ref095]\] Due to very few studies having a comparison group of non-stress test, we compared and presented studies according to methodological biases. In the second step, we analyzed patients who only received stress testing, using the number of 30-day mortality events in each study and the total sample size of the sample that received the stress test. We calculated the pooled estimates (effect size or proportion) after Freeman-Tukey Double Arcsine Transformation\[[@pone.0219145.ref096]\] to stabilize the variances.\[[@pone.0219145.ref097]\] This is a procedure specific to binomial data and uses exact methods. We determined heterogeneity across studies using the I^2^ statistic, constructed funnel plots and assessed funnel plot symmetry using regression test.\[[@pone.0219145.ref098]\] Then, we explored potential sources of heterogeneity among the studies based on study characteristics (stratified analysis) and according to methodological biases (sensitivity analysis) using random effects meta-regression, calculated the corresponding I^2^ statistic for respective strata and p-for-interaction.

Results {#sec011}
=======

Among 1807 studies identified in our literature search, 79 distinct studies from 84 articles met inclusion criteria ([Fig 1](#pone.0219145.g001){ref-type="fig"}). The year of publication was from 1981 to 2015 and the year of enrollment ranged from 1976 to 2010. The final sample consisted of 297,534 participants with mean age ranging from 32 to 75 years, and the percentage of men in the studies ranging from 19 to 100% ([Table 1](#pone.0219145.t001){ref-type="table"}). The follow-up period varied between peri-operative to 168 months. A total of 46,015 patients received some form of stress test. Only 40 studies reported 30-day mortality.

10.1371/journal.pone.0219145.t001

###### Clinical characteristics of clinical trials and cohort studies, N = 79.

![](pone.0219145.t001){#pone.0219145.t001g}

  Author               Design   Year   Surgery type              No. of participants   \% male   Mean age   Type of stress test   No. receiving test   No. with CAD   No. with diabetes   No. with ischemia   No. having surgery   Months follow-up     No. receiving test at end of study
  -------------------- -------- ------ ------------------------- --------------------- --------- ---------- --------------------- -------------------- -------------- ------------------- ------------------- -------------------- -------------------- ------------------------------------
  Falcone, R.A.        RCT      2003   S1, S4                    99                    68        65         T0, T4, T7            46                   103            26                  7                   99                   12                   46
  Poldermans, D.       RCT      2006   S1                        770                   77        68         T0, T1                386                  72             85                  99                  770                  36                   386
  Poldermans, D.       RCT      2007   S1                        101                   88        70         T1                    101                  99             33                  101                 98                   12                   101
  Mondillo, S          RT       2002   S1                        188                   76        67         T4, T6, T7            61                   52             43                  52                  188                  1                    188
  Cutler, B.S.         cohort   1981   S1                        284                   70        62         T2                    284                                                     50                  100                  periop               284
  Arous, EJ            cohort   1984   S1                        808                                        T2                    808                                                     135                 89                   60                   135
  Smith, T.P.          cohort   1984   S2                        22                    19        56         T9                    22                   7                                  CPX                 22                   1                    22
  Carliner, N.         cohort   1985   S1, S3, S4, S5, S6, S11   200                   70        59         T2                    200                  57                                 30                  198                  1                    200
  McPhail, N.          cohort   1988   S1                        101                                        T2                    101                                                     21                  100                                       101
  Lette J.             cohort   1989   S1, S4, S5, S6, S7, S9    66                    53        59         T4                    66                   18             14                  21                  60                                        60
  McPhail, N.          cohort   1989   S1                        64                    77        66         T0, T2, T4            60                                                      34                                                            31
  Boysen,P.G.          cohort   1990   S2                        70                    88        62         T2                    17                   0                                                      17                   1                    17
  Joyce, W             cohort   1990   S1                        77                    68        68         T2                    77                   42                                 21                  77                   1                    77
  Holley               cohort   1991   S7                        189                   68        40         T0, T5                141                  0              189                 41                  122                  60                   189
  Holden               cohort   1992   S2                        23                    81        68         T9, T10               16                                                      0                   16                   18                   16
  Reifsnyder, T.       cohort   1992   S1                        126                   100       65         T4, T5                103                  61             26                  51                  141                  4                    103
  Davila-Roman, V.G.   cohort   1993   S1                        98                    69        67         T7                    98                   59             18                  23                  93                   27                   
  Epstein, S.K.        cohort   1993   S2                        42                    98        62         T9                    42                   10                                 CPX                 42                   1                    42
  Kaaja, R             cohort   1993   S1                        58                    67        59         T2                    58                   17                                 14                  58                   0.5                  58
  Older P.             cohort   1993   S1, S4                    191                   55        70         T9                    187                                                     CPX                 187                                       187
  Poldermans, D.       cohort   1993   S1                        136                   85        68         T7                    136                  56             15                  35                  136                  postop               136
  Seeger, J.M.         cohort   1994   S1                        318                             64         T0, T4, T5            146                  82             37                  70                  318                  132                  146
  Poldermans, D.       cohort   1994   S1                        106                             75         T7                    106                                                     40                  104                  22                   106
  Poldermans, D.       cohort   1994   S1                        187                   84        69         T7                    187                  69             22                  56                  187                  25                   187
  Bollinger, C.T       cohort   1995   S2                        84                    68        63         T9                    25                                                                          25                   6                    25
  Mocini, D            cohort   1995   S1                        60                    97        67         T4, T6                52                   4              16                  18                  55                   12                   52
  Poldermans, D.       cohort   1995   S1                        302                   85        67         T7                    302                  93             33                  72                  302                  In-hospital          302
  Donovan, C.L         cohort   1996   S8                        190                   52        50         T0, T7                165                  7              30                  11                  71                   postop               165
  Erickson, C.A.       cohort   1996   S1                        209                   88        67         T0, T4                147                  90             31                  91                  209                  60                   147
  Pellikka, P.A.       cohort   1996   S1, S4, S9, S11           98                    78        73         T7                    98                   28                                 28                  80                                        98
  D'Angelo, A.J.       cohort   1997   S1                        113                   79        72         T0, T4                20                   52             12                  7                   113                  postop               20
  Deville, C.          cohort   1997   S1                        283                   91        68         T0, T2                204                  123                                21                  283                  168                  204
  Kryzhanovski, V.A.   cohort   1997   S8                        88                    71        54         T0, T4, T5            64                   8                                  8                                                             64
  Larsen, K.R.         cohort   1997   S2                        97                    69        64         T9                    97                                                      CPX                 97                   1                    97
  Richter Larsen, K.   cohort   1997   S2                        97                              64         T2                    97                                                                                                                    97
  Van Damme H.         cohort   1997   S1                        156                   68        66         T4, T7                150                  76             28                  30                  142                  postop               150
  Poldermans, D.       cohort   1997   S1                        316                   82        67         T7                    316                  92             32                  84                  316                  30                   316
  Nugent               cohort   1998   S1                        36                    80        71         T9                    36                   10             2                                       30                   12                   30
  Won, A               cohort   1998   S1                        171                   94        69         T0, T1                136                  47             15                  36                  171                  60                   160
  Fleisher, L.A.       cohort   1999   S1                        1666                                       T0, T1                261                                                                         1666                 12                   261
  Gauss, A.            cohort   1999   S1, S4                    204                   79        67         T2                    204                  90             35                  72                  185                  1                    204
  Das, M.K.            cohort   2000   S3, S4, S9, S11           530                   57        71         T7                    530                  264            113                 214                 530                  postop               530
  Lacroix, H.          cohort   2000   S1                        200                   95        65         T0, T4, T7                                                16                  154                 200                  0.25                 195
  Williams, K.         cohort   2000   S8                        121                   64        53         T7                    121                                                     2                   61                                        121
  Farid, I.            cohort   2002   S1, S4, S6, S9, S11       181                                        T4, T5, T7, T8        181                                                     27                  178                  12                   181
  Villani, F           cohort   2003   S2                        150                   94        57         T9                    150                  30                                 CPX                 150                  1                    150
  Ali, M               cohort   2004   S7                        190                   63        43         T0, T2                47                   43                                 9                   47                   60                   47
  Epstein, S.K.        cohort   2004   S8                        156                   59        46         T9                    156                                                     CPX                 59                   25                   156
  Golzar, JA           cohort   2004   S1                        63                    62        64         T4, T5                63                                  10                  0                   63                   12                   63
  Park, K.W.           cohort   2005   S1                        31                              72         T0, T4, T5            28                   15             17                  28                  31                   periop               28
  Win, T               cohort   2005   S2                        101                   62        68         T0, T9                99                                                      CPX                 101                  1                    99
  McMcCullough, P.A.   cohort   2006   S10                       109                   25        46         T9                    109                  11             39                  CPX                 109                  1                    109
  Bai, J.              cohort   2007   S11                       1570                            68         T4                    1351                                193                 352                 1351                 1                    1351
  Schouten, O.         cohort   2007   S1                        77                    95        73         T7                    77                   63             11                  35                  77                   1                    77
  Forshaw, M.J.        cohort   2008   S3                        97                                         T9                    78                                                      CPX                 78                   hospital discharge   78
  Gonzalez, CA         cohort   2008   S2                        130                   69        52         T0, T10               95                                                                          130                  96                   95
  Jaroszewski, D       cohort   2008   S2, S3                    294                   98        62         T0, T2, T4, T5, T7    184                  88             65                  75                  294                  1                    184
  Schouten, O.         cohort   2008   S1                        124                   92        74         T7                    124                  107            18                  58                  124                  72                   124
  Afolabi, B.A.        cohort   2009   S10                       157                   31        47         T2, T3, T6            78                   18             47                  25                                       1                    78
  Brunelli, A.         cohort   2009   S2                        285                             67         T9                    263                  47                                                     263                  postop               263
  Kasikcioglu, E.      cohort   2009   S2                        49                    90        61         T9                    49                   6                                  CPX                 49                                        49
  Matyal R.            cohort   2010   S1                        503                   65                   T4                    503                  309            264                 160                 503                  hospital stay        503
  Snowden, C.P.        cohort   2010   S1, S4                    171                   70        69         T9                    171                  35             30                  CPX                 123                  1                    171
  Wijeysundera, D.N.   cohort   2010   S1, S2, S4, S6, S9        271082                49        68         T0, T1                23991                26562          49323                                   271082               12                   23991
  Aalten, J.           cohort   2011   S7                        349                   56        50         T0, T3, T7            227                  103                                15                  4                    1                    227
  Bub, G.L             cohort   2011   S1                        246                   82        74         T0, T1                179                  208            50                  27                  246                  1                    179
  Shetty, V.J.         cohort   2011   S9                        109                   28                   T7                    109                  16             21                  12                  103                  postop               109
  Thompson, A.R.       cohort   2011   S1                        102                   92        75         T9                    102                  44             9                   CPX                 63                   33                   102
  Ausania, F           cohort   2012   S4                        50                    66        64         T0, T9                20                   12             14                                                           33                   20
  Hartley              cohort   2012   S1                        415                   84                   T9                    415                  179            43                                      415                  3                    415
  Koh, A.S.            cohort   2012   Not specified             176                   59        61         T4, T5                176                                 67                  65                  107                  3                    176
  Prentis, J.M.        cohort   2012   S8                        182                             52         T7, T9                182                                                     CPX, 1 DSE          64                   3                    182
  Prentis, J.M.        cohort   2012   S1                        185                   87        73         T9                    185                  83             24                  CPX                 185                  hospital stay        185
  James, S             cohort   2014   S1, S4                    100                   72        68         T0, T9                83                   23             14                                      83                   1                    83
  Prentis, J.M.        cohort   2013   S6                        82                    59        69         T9                    82                                                      CPX                 74                   hospital stay        82
  Grant, SW            cohort   2014   S1                        506                   83        73         T9                    506                  227            48                  49                  506                  67                   506
  Snipelisky, D.       cohort   2014   S8                        66                    68        59         T7                    66                   28             30                  28                  66                   60                   66
  West, M.A.           cohort   2014   S4                        136                   65        71         T9                    136                  14             16                  CPX                 136                  1                    136
  West, M.A.           cohort   2014   S4                        95                    79        66         T9                    95                   14             18                  CPX                 95                   12                   95
  Castleberry, A.W.    cohort   2015   S2                        9526                  59        32         T10                   9526                                1674                6MWT                9526                 60                   9526
  Chaikriangkrai, K.   cohort   2015   S2                        324                   58        57         T10                   324                  144                                6MWT                324                  40                   324
  Marjanski T.         cohort   2015   S2                        318                   58        63         T0, T10               253                                                     6MWT                318                  3                    253
  Tolchard S.          cohort   2015   S6                        105                   84        71         T9                    105                  24             15                  CPX                 105                  3                    105
  Ulyett, S.           cohort   2015   S4                        405                   51        66         T0, T9                101                                 43                  CPX                 405                  77                   101

RCT = randomized control trial, RT = randomized trial, no control

**Types of surgery**: S1 = vascular, S2 = lung, S3 = thoracic, S4 = abdominal, S5 = gynecological, S6 = urological, S7 = renal transplant, S8 = liver transplant, S9 = orthopedic, S10 = gastric bypass, S11 = other

**Types of stress test**: T0 = no stress test, T1 = type unspecified, T2 = exercise tolerance test, T3 = nuclear stress test- type unspecified, T4 = pharmacological nuclear test, T5 = exercise nuclear test, T6 = echo stress test- type unspecified, T7 = dobutamine stress echo, T8 = exercise echo stress test, T9 = cardiopulmonary exercise test, T10 = six-minute walk test

6MWT: 6-minute walk test, CPX: cardiopulmonary exercise test

Only six studies had any form of stress test, 30-day mortality and had a comparison of stress test versus non-stress test groups (n = 3219). The range of mean age of patients was 47 to 68 years and the percentage of males was 31% to 88%. Four studies had vascular, one had lung, one abdominal and one gastric bypass surgical procedure. Two studies were randomized clinical trials and the remaining four were cohort studies. Of these, patients in four of these studies had specific surgeries, either vascular, lung, abdominal or gastric bypass procedures. [Fig 2](#pone.0219145.g002){ref-type="fig"} presents the forest plot with RRs of individual studies scattered around the null effect line at one (RR = 0.79 (95% CI = 0.35--1.80). Heterogeneity was high (53.8%), with weak evidence (p = 0.090). The scatter of effect estimates and the prediction line from meta-regression models indicated symmetry, with all studies in the funnel of non-significance at p\>0.05 ([S3 Fig](#pone.0219145.s003){ref-type="supplementary-material"}). The regression test was negative (p = 0.92). In the assessment of biases, both randomized clinical trials were of good methodological quality while the cohort studies had different biases- mainly comparability of the cohorts ([S4 Fig](#pone.0219145.s004){ref-type="supplementary-material"}).

![Meta-analysis of 30-day mortality in a comparison of stress test versus no stress test among non-cardiac surgery patients, N = 6 studies.\
There are only 6 studies which had both groups (had stress test versus no stress test) among 79 studies.](pone.0219145.g002){#pone.0219145.g002}

Among the 79 studies, only 40 studies had 30-day mortality assessed as an outcome. These 40 studies were published from 1984 to 2015 and a total sample size of 16,886. The range of mean age of patients was from 32 to 75 years and the percentage of males from 19% to 100%. 21 studies had vascular surgery, 11 studies had lung surgery, three had thoracic surgery, seven had abdominal surgery, two had gynecological procedures, two had urological procedures, three had renal transplants, one had orthopedic procedures, and two had gastric bypass surgery. [Fig 3](#pone.0219145.g003){ref-type="fig"} presents the forest plot with proportion (%) of 30-day mortality rates of individual studies scattered around the null effect line at zero. The pooled 30-day mortality rate was 1.98% and 95% CI was 1.25%-2.85%. Heterogeneity was high (77.4%), indicating inconsistencies among studies, and the evidence for heterogeneity was strong (p\<0.0001). The results of meta-analysis using standard meta-analysis and using procedures specific to binomial data with continuity correction are presented in [S3](#pone.0219145.s003){ref-type="supplementary-material"} and [S4](#pone.0219145.s004){ref-type="supplementary-material"} Figs.

![Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures specific to binomial data and exact methods, N = 40.\
ES is effect size- here it is %. Here we calculate the pooled estimate after Freeman-Tukey Double Arcsine Transformation (Freeman, M. F., and Tukey, J. W. 1950) to stabilize the variances.](pone.0219145.g003){#pone.0219145.g003}

Stratified analysis of 30-day mortality among non-cardiac surgery patients who received stress test is presented in [Table 2](#pone.0219145.t002){ref-type="table"}. After excluding three studies with a comparison group, the pooled rate estimates reduced slightly towards the null (1.75%, 95% CI = 1.05%-2.58%) ([S5 Fig](#pone.0219145.s005){ref-type="supplementary-material"}). Stratified analysis by type of stress test ([Table 2](#pone.0219145.t002){ref-type="table"}) demonstrated no evidence of difference in effect estimates by stress test categories. Cumulative meta-analysis of 30-day mortality is presented in [S6 Fig](#pone.0219145.s006){ref-type="supplementary-material"}. Stratified analysis by decades of publication year demonstrated highest mortality rate between 1981 to 1989 (5.82%, 95% CI = 0.09%-17.08%) and declined with decades, the pooled estimate during 2010 to 2015 was 1.60% (95% CI = 0.57--3.05) ([S7 Fig](#pone.0219145.s007){ref-type="supplementary-material"}). There were no differences in pooled estimates by study size ([S8 Fig](#pone.0219145.s008){ref-type="supplementary-material"}) or types of non-cardiac surgery ([Table 2](#pone.0219145.t002){ref-type="table"}, [S9](#pone.0219145.s009){ref-type="supplementary-material"}--[S19](#pone.0219145.s019){ref-type="supplementary-material"} Figs).

10.1371/journal.pone.0219145.t002

###### Stratified analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures specific to binomial data and exact methods by study characteristics, N = 40.

![](pone.0219145.t002){#pone.0219145.t002g}

                                                \# of studies   \# of patients   ES (95% CI), p                I^2^, p-value    P-interaction
  --------------------------------------------- --------------- ---------------- ----------------------------- ---------------- -------------------------------------------
  All                                           40              16,886           1.98 (1.25--2.85), \<0.0001   77.4, \<0.0001   
  Comparison group                                                                                                              0.099
   No                                           37              15,916           1.75 (1.05--2.58), \<0.0001   75.4, \<0.0001   
   Yes                                          3               970              5.11 (0.04--15.8), 0.04       \-               
  Vascular surgery                                                                                                              0.81
   No                                           19              11,968           1.67 (0.58--3.15), \<0.0001   83.6, \<0.0001   
   Yes                                          21              4,918            2.36 (1.36--3.58), \<0.0001   66.7, \<0.0001   
  Lung surgery                                                                                                                  0.081
   No                                           29              6,132            1.65 (0.89--2.60), \<0.0001   69.5, \<0.0001   
   Yes                                          11              10,754           3.34 (1.40--2.85), \<0.0001   80.9, \<0.0001   
  Abdominal surgery                                                                                                             0.73
   No                                           33              15,986           2.06 (1.24--3.04), \<0.0001   78.2, \<0.0001   
   Yes                                          7               900              1.65 (0.29--3.77), \<0.0001   65.8, \<0.0001   
  Other surgery                                                                                                                 0.27
   No                                           31              15,343           2.47 (1.64--3.43), \<0.0001   70.3, \<0.0001   
   Yes                                          9               1,543            0.76 (0.02--2.18), 0.03       70.4, \<0.0001   
  Stress test type                                                                                                              0.33[\*](#t002fn004){ref-type="table-fn"}
   Multiple                                     12              3849             2.14 (0.38--4.86), \<0.0001   84.7, \<0.0001   
   ETT[^a^](#t002fn001){ref-type="table-fn"}    4               539              1.30 (0.40--2.57), \<0.0001   0.00, 0.64       
   Echo                                         2               222              1.74 (0.29--4.06), \<0.0001                    
   Nuclear                                      6               684              1.29 (0.00--4.37), 0.07       75.4, \<0.0001   
   CPX[^b^](#t002fn002){ref-type="table-fn"}    14              1748             2.62 (1.37--4.18), \<0.0001   60.7, \<0.0001   
   6MWT[^c^](#t002fn003){ref-type="table-fn"}   2               9844             3.88 (3.50--4.27), \<0.0001                    
  Time period                                                                                                                   0.47
   1981--1989                                   3               288              5.82 (0.09--17.1), 0.03       67.0, \<0.0001   
   1990--1999                                   14              3,006            2.65 (1.14--4.63), \<0.0001   79.0, \<0.0001   
   2000--2009                                   13              2,284            1.47 (0.27--3.32), \<0.0001   83.2, \<0.0001   
   2010--2015                                   10              11,308           1.60 (0.57--3.05), \<0.0001   77.4, \<0.0001   
  Country                                                                                                                       0.73
   US & Canada                                  18              12,997           1.29 (0.40--2.53), \<0.0001   76.1, \<0.0001   
   UK                                           9               1,313            1.94 (0.97--3.18), \<0.0001   36.8, 0.12       
   Other                                        13              2,576            3.42 (1.40--6.16), \<0.0001   85.2, \<0.0001   

^a^ ETT: exercise tolerance test;

^b^ CPX: cardiopulmonary exercise test;

^c^ 6MWT:6-minute walk test;

\* p-interaction was calculated without including results from echo and 6MWT due to insufficient number of studies.

The assessment of biases using a sensitivity analysis of stratifying by eight sections in selection, comparability, and outcomes are presented in [Table 3](#pone.0219145.t003){ref-type="table"}. While the study results are heterogeneous, there were no differences by methodological variables using meta-regression except for demonstration that outcome of interest was not present at the start of the study (p-interaction = 0.048). However, there were only three studies in the no category.

10.1371/journal.pone.0219145.t003

###### Sensitivity analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures specific to binomial data and exact methods by quality characteristics of the study, N = 40.

![](pone.0219145.t003){#pone.0219145.t003g}

                                                                             \# of studies   \# of patients   ES (95% CI), p                I^2^, p-value    P-inter
  -------------------------------------------------------------------------- --------------- ---------------- ----------------------------- ---------------- ---------
  Representativeness of the exposed cohort                                                                                                                   0.039
   Somewhat                                                                  2               181              9.45 (4.61--15.7), \<0.0001   \-               
   Truly                                                                     38              16,705           1.80 (1.10--2.63), \<0.0001   77.2, \<0.0001   
  Ascertainment of exposure                                                                                                                                  \-
   From secure record                                                        40              16,886           1.98 (1.25--2.85), \<0.0001   77.4, \<0.0001   
   Other                                                                     0                                                                               
  Demonstration that outcome of interest was not present at start of study                                                                                   0.048
   Yes                                                                       37              16,527           1.76 (1.05--2.61), \<0.0001   77.8, \<0.0001   
   No                                                                        3               359              7.48 (1.73--16.1), \<0.0001   \-               
  Comparability of cohorts on the basis of the design or analysis (n = 8)                                                                                    0.73
   Yes                                                                       2               869              2.94 (1.42--4.89), \<0.0001   \-               
   No                                                                        6               2,578            1.68 (0.25--3.98), \<0.0001   72.8, \<0.0001   
  Comparability of cohorts on other factors (n = 8)                                                                                                          0.72
   Yes                                                                       1               770              3.89 (2.19--6.33), \<0.0001   68.8, \<0.0001   
   No                                                                        7               2,677            1.40 (0.17--3.40), 0.01       \-               
  Assessment of outcome                                                                                                                                      0.80
   Independent blind                                                         7               1,813            2.41 (0.36--5.81), \<0.0001   87.9, \<0.0001   
   Records/ self-report                                                      33              15,073           1.88 (1.12--2.78), \<0.0001   73.4, \<0.0001   
  Was follow-up long enough for outcomes to occur                                                                                                            0.12
   Yes                                                                       34              16,380           1.77 (1.03--2.66), \<0.0001   , \<0.0001       
   No                                                                        6               506              4.10 (1.41--7.83), \<0.0001   , \<0.0001       
  Adequacy of follow up of cohorts                                                                                                                           0.39
   Complete follow up                                                        33              6,490            2.30 (1.37--2.85), \<0.0001   85.2, 0.07       
   Incomplete follow up                                                      7               10,396           0.91 (0.00--3.11), \<0.0001   73.2, \<0.0001   

Selection of the non-exposed cohort was dropped from the analysis since this analysis is for single cohort of those who received stress test.

The contour plot demonstrates the scatter of effect estimates with log of 30-day mortality rate on the x-axis and corresponding standard error on the y-axis, indicating potential publication bias and small study effects ([S20 Fig](#pone.0219145.s020){ref-type="supplementary-material"}). An asymmetric funnel plot suggests the presence of small study effects due to methodological problems resulting in publication bias may have resulted in an overestimation of effects. The scatter of effect estimates from meta-regression models with standard error as an explanatory variable indicated asymmetry and suggests missing studies in the white area of non-significance on one side. The regression test for asymmetry was negative (p = 0.17).

Discussion {#sec012}
==========

This study is the largest systematic review and meta-analysis of pre-operative stress testing prior to non-cardiac surgery. Overall, we observed a general lack of quality of studies available to estimate pooled risk of 30-day mortality. We observed three main findings. First, the analysis of 40 studies out of which 36 without a comparator group, indicative of low methodological quality, observed that the 30-day mortality rate to be 1.98 with high heterogeneity between studies. Second, the 30-day mortality risk associated with pre-operative stress test versus no pre-operative test was inconclusive. Third, among the 1,807 studies considered for this analysis, 485 (26.8%) were excluded because they did not assess hard outcomes such as mortality, incidence of MI or incidence of heart failure. Among the 79 studies selected, only 40 (50.6%) presented 30-day mortality.

Of the 79 studies included in our analysis, there were only six studies with a comparison group of which three randomized controlled trials that met our inclusion criteria. We included two studies (THE DECREASE II and DECREASE V trials)\[[@pone.0219145.ref073], [@pone.0219145.ref074]\] for which significant doubt was raised regarding the validity of their findings, owing to multiple issues as outlined in the 2012 Erasmus MC Report that investigated these studies.\[[@pone.0219145.ref099]\] However, we included these studies in our analysis, since these articles were not retracted. The remainder were group cohort studies, often retrospective in nature, and did not include a comparison group of those patients who had undergone stress testing versus those who did not. Among the six studies comparing stress testing versus no stress testing, there was no significant difference in 30-day mortality between the groups, and the overall event rate was low. Notably, two of these studies were excluded from the analysis because their event rates were zero. While this conclusion suggests that stress testing has little impact on 30-day mortality in patients awaiting non-cardiac surgery, it is also clear that in the current body of literature, there are very few studies designed to adequately answer this question. Importantly, it is difficult to discern from the available studies if the results of pre-operative stress testing influenced down-stream decision making that may have led to the cancellation or postponement of surgery, or to other cardiovascular interventions that were implemented with the aim of reducing peri-operative risk. This appears to be the case in 17 studies that reported coronary revascularization prior to surgery ([Table 1](#pone.0219145.t001){ref-type="table"}).

The majority of studies (21/40) included a population of patients awaiting vascular surgery. There was no significant difference in 30-day post-operative mortality among vascular surgery patients compared with other types of surgeries. However, the 30-day mortality rate tended to be higher (p = 0.08) among those who underwent lung surgeries (3.34%) compared to other types of surgeries (1.65%).

Since surgical techniques, anesthesia and peri-operative management have evolved over time, we evaluated studies relative to the time periods of patient enrollment. Three studies (288 patients) enrolled patients prior to 1990, 14 studies in the 1990s (3,006 patients) and 13 studies in the 2000s (2,284 patients). The majority of patients (11,308) included in this analysis were enrolled after 2010. These latter ten studies reflect a patient population exposed to the most contemporary techniques, with a 30-day post-operative mortality rate of 1.68.

While extracting data from these studies, we noted many incomplete descriptions of stress testing methodology. A large proportion of studies did not specify the exact type of stress test that was performed or included multiple types of stress tests into a single analysis. When nuclear or echo imaging stress tests were performed, exercise and pharmacological tests were most often reported as a single type of imaging stress test. Moreover, there was significant variability in how an abnormal stress test was defined, or it was often not defined at all. Hence, it is not surprising that the heterogeneity among these studies was high, thus limiting our ability to precisely analyze whether the type of stress testing used or abnormal results had any effect on patient outcomes. The duration of follow-up reported in the studies was not specified in many of the studies. Most of the studies did not have independent blinded or central adjudication of outcomes, but rather used record linkages that and may have been subject to reporting error.

Importantly, there was no ischemia-specific extractable aggregate data available in any of the 79 studies. Therefore, we were unable to perform stratified analysis by evidence of ischemia. This was similarly the case with peak exercise work rate or other test-specific measured variables. Notably, 17 studies included patients (251 in the sample) that underwent stress testing and subsequent revascularization prior to surgery leading to an important verification or workup bias, further limiting conclusions that could be derived from the reported results. Seven of the studies did not report whether revascularization had occurred prior to surgery.

Since the largest proportion of studies in our analysis included those in which cardiopulmonary testing (CPX) was performed, these deserve special comment. Only 14 out of 27 studies reported 30-day post-operative mortality which averaged 2.6%. Qualitatively, it appears that a higher exercise capacity, as measured by peak oxygen uptake (VO2), was associated with lower mortality and fewer short-term (\<30 days) post-operative complications. Many of the studies provided evidence supporting this association; however, there was significant variation regarding the variables that were used to segregate patients into different post-operative risk tiers (e.g. ventilatory or anaerobic threshold, peak VO2, percentage of predicted maximal VO2 achieved), as well as the cutoff limits for each of these variables. As such, there was no specific variable or cutoff threshold that was consistent.

It is difficult to evaluate publication bias in this meta-analysis given the small number of trials. Based on the funnel plot of these six included studies, it is possible that the asymmetry may be due to reporting bias; however, the results may be more likely be attributable to chance given the small number of included trials, as well as some component of heterogeneity, as mentioned above.

Despite four decades of research since the inception of the multifactorial index of cardiac risk in non-cardiac surgical procedures and medical advances in nuclear stress testing, there are very limited quality data in the literature.\[[@pone.0219145.ref100]\] In fact, there have been only six meta-analyses examining pre-operative pharmacologic stress testing prior to non-cardiac surgery with the most recent analysis in 2006.\[[@pone.0219145.ref101]--[@pone.0219145.ref106]\] Due to the rapid advances in nuclear cardiology over the past few decades, three of the studies are outdated as they included planar imaging and SPECT without CT.\[[@pone.0219145.ref101]--[@pone.0219145.ref103]\] One meta-analysis exclusively evaluated end-stage renal disease patients undergoing kidney and/or pancreatic transplants and found that positive myocardial perfusion studies were associated with increased risk of myocardial infarction and cardiac death.\[[@pone.0219145.ref104]\] Two of the more recent meta-analyses have revealed that moderate to large perfusion defects portend a worse peri-operative morbidity.\[[@pone.0219145.ref105], [@pone.0219145.ref106]\] A meta-analysis evaluating thallium imaging and stress echocardiography in patients undergoing elective non-cardiac surgery\[[@pone.0219145.ref106]\] found a moderate to large defect and was predictive of 30-day myocardial infarcts and death (7.5% and 8.1% for stress echocardiograms and stress scintigraphy).\[[@pone.0219145.ref106]\]

Based on the 30-day mortality rate of 1.98% (95% CI 1.25% to 2.85%) reported in our analysis, for demonstrating stress test to be effective in reducing the mortality rate by 50%, the expected 30-day mortality rate in the non-stress test group would be between 2.97% (1.88% to 4.28%). The corresponding rate ratio will be 0.67. If the expected reduction in mortality rate was 80%, then the expected 30-day mortality rate in the non-stress group ranges between 3.56% (95% CI 2.25% to 5.13%). The corresponding rate ratio will be 0.55. For a superiority trial, with two-sided type 1 error of 0.05, power of 90%, randomized 1:1, comparing 1.98% to 2.97% stress test versus no stress test, the sample size for each group was 5,173 (total 10,346). For a superiority trial, with two-sided type 1 error of 0.05, power of 90%, randomized 1:1, comparing 1.98% to 3.56% stress test versus no stress test, the sample size for each group was 2,265 (total 4530). Importantly, the results of the stress test would need to be blinded by the study investigators in order to avoid the work up bias that is evident in several studies included in our systematic review. Such a study would be very difficult to conduct without the exclusion of patients who demonstrated stress test results that were predictive of a high short-term adverse event rate even without the performance of the planned surgery.

Conclusion {#sec013}
==========

Due to a large heterogeneity among the studies, our meta-analysis justifies the current American\[[@pone.0219145.ref002]\] and European guidelines\[[@pone.0219145.ref003]\] and as of 2018 does not support routine or indiscriminate pre-operative stress testing prior to non-cardiac surgery. Overall, the studies lacked methodological rigor that precludes our ability to draw any conclusions regarding whether or not pre-operative stress testing offers any valuable information to predict 30-day mortality following non-cardiac surgery. These studies are inadequate to assess whether judicious, clinically-driven pre-operative stress testing of any type among patients with specific symptoms or signs that suggest high-risk coronary artery disease, or among those undergoing a particular type of non-cardiac surgery, affect decisions, treatments and interventions that might mitigate post -operative mortality.
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###### Contour funnel plot to highlight the effect estimate and standard error of the studies included in this meta-analysis with a comparison of stress test versus no stress test, N = 6 studies.

A larger study will have smaller standard error, indicative of better statistical precision and vice versa. Studies with large sample size are scattered on the top of the triangle, indicative of minimal bias. Studies with small sample size are on the base of the triangle. The contours of the funnel plot indicate the measures of significance; p\<1%, 1%\<\<p5%, 5%\<p\<10% are in shades of grey and the white area indicate p\>10%. Eggers test for absence of small study effects was not significant, p = 0.92, indicating that the effects seen in small studies vary from those estimated in larger studies and may be due to the instability of the effect sizes in small sizes or reporting bias.

(PDF)

###### 

Click here for additional data file.

###### Bias within eligible studies in a comparison of stress test versus no stress test among non-cardiac surgery patients, N = 6 studies.

For each study, the presence (+) and absence (-) of a characteristic are recorded. If the characteristic was not clear in the trial, then it was marked as uncertain (?).
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using standard meta-analysis method, N = 40.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures specific to binomial data with continuity correction, N = 40.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures specific to binomial data and exact methods, N = 40.

(PDF)
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Click here for additional data file.

###### Cumulative meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by time period of enrollment, N = 40.

ES is effect size- here it is %. The pooled estimate is calculated after Freeman-Tukey Double Arcsine Transformation (Freeman, M. F., and Tukey, J. W. 1950) to stabilize the variances.

(PDF)
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by time period of publication, N = 40.

Using Fig 6 specs by time period of publication. ES is effect size- here it is %. The pooled estimate is calculated after Freeman-Tukey Double Arcsine Transformation (Freeman, M. F., and Tukey, J. W. 1950) to stabilize the variances.

(PDF)
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by study size, N = 40.

Using Fig 6 specifications by time period of publication. ES is effect size- here it is %. The pooled estimate is calculated after Freeman-Tukey Double Arcsine Transformation (Freeman, M. F., and Tukey, J. W. 1950) to stabilize the variances.

(PDF)
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- vascular.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- lung.

(PDF)
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- thoracic, not lung.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- abdominal.

(PDF)
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- gynecological.

(PDF)

###### 

Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- urological.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- renal transplant.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- liver transplant.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- orthopedic.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- gastric bypass.
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Click here for additional data file.

###### Meta-analysis of 30-day mortality among non-cardiac surgery patients who received stress test using procedures by type of surgery- other.
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Click here for additional data file.

###### Contour funnel plot to highlight the effect estimate and standard error of 30-day mortality related to stress test in studies included in this meta-analysis, N = 40 studies.

Eggers test = 0.17.
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###### Search criteria.
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###### Phase 1 screening or Abstract screening inclusion and exclusion criteria.
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###### Results of phase 1 screening or abstract screening.
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###### Phase 2 screening or full-text screening inclusion and exclusion criteria.
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###### Newcastle Ottawa Quality Assessment Scale.
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###### PRISMA 2009 checklist.
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